We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
+29.93%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.38B
AUM Growth
-$1.54B
Cap. Flow
-$2.13B
Cap. Flow %
-89.3%
Top 10 Hldgs %
100%
Holding
112
New
–
Increased
–
Reduced
2
Closed
110

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CAVA icon
CAVA Group
CAVA
+$610M
2
SRRK icon
Scholar Rock
SRRK
+$93.8M
3
KYMR icon
Kymera Therapeutics
KYMR
+$89.7M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
+$86.1M
5
ARWR icon
Arrowhead Research
ARWR
+$82.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 91.02%
2 Healthcare 8.98%
3 Communication Services 0%
4 Real Estate 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYTX icon
101
Kyverna Therapeutics
KYTX
$430M
– –
-200,000
Closed -$1.5M
MGX icon
102
Metagenomi Therapeutics
MGX
$45.6M
– –
-300,000
Closed -$1.22M
RBRK icon
103
Rubrik
RBRK
$14.8B
– –
-35,000
Closed -$1.07M
RAPP
104
Rapport Therapeutics
RAPP
$1.96B
– –
-350,000
Closed -$8.14M
ONC
105
BeOne Medicines Ltd
ONC
$33.9B
– –
-303,369
Closed -$43.3M
KLRS
106
Kalaris Therapeutics
KLRS
$80.9M
– –
-286,833
Closed -$4.77M
ACHL
107
DELISTED
Achilles Therapeutics
ACHL
– –
-755,375
Closed -$616K
SYRS
108
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-2,505,013
Closed -$12.9M
OMGA
109
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
– –
-1,323,530
Closed -$2.74M
PFTAW
110
DELISTED
Perception Capital Corp. III Warrant
PFTAW
– –
-126,666
Closed -$3.55K
GRTS
111
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-3,030,952
Closed -$1.87M
MORF
112
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-2,525,998
Closed -$86.1M
1 2 3 4
5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q3 2024 Portfolio in Review

As of Q3 2024, Artal Group held 112 positions worth $2.38B, down 39% from $3.92B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Artal Group withdrew a net $2.13B in Q3 2024, closing 110 positions and reducing 2 holdings. Its most notable exit was Scholar Rock, an estimated $93.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 91% of assets, up from 56% a quarter earlier, followed by Healthcare and Communication Services.

  • Artal Group's biggest Q3 2024 reduction was CAVA Group, cutting an estimated $610M.
  • Artal Group fully exited Scholar Rock in Q3 2024, selling an estimated $93.8M.
  • Artal Group's ten largest holdings make up 100% of its $2.38B portfolio in Q3 2024.
  • Artal Group opened 0 new positions and closed 110 in Q3 2024.
  • Artal Group's portfolio value fell 39% quarter-over-quarter to $2.38B.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.